MedPath

COMPARISON OF LEVETIRACETAM AND SODIUM VALPROATE MONOTHERAPY IN CHILDHOOD EPILEPSY

Phase 3
Conditions
Health Condition 1: G409- Epilepsy, unspecified
Registration Number
CTRI/2023/12/060737
Lead Sponsor
DR TARANG KALARIA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children 1 year to 18 years of age with newly diagnosed epilepsy.

Exclusion Criteria

(1)Previous treatment with AEDs prior to enrollment

(2)Neurodegenerative disorder

(3)Static encephalopathy

(4)CNS malformation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath